ATE49958T1 - Pharmazeutische zusammensetzungen mit immunodepressivwirkung. - Google Patents

Pharmazeutische zusammensetzungen mit immunodepressivwirkung.

Info

Publication number
ATE49958T1
ATE49958T1 AT85401027T AT85401027T ATE49958T1 AT E49958 T1 ATE49958 T1 AT E49958T1 AT 85401027 T AT85401027 T AT 85401027T AT 85401027 T AT85401027 T AT 85401027T AT E49958 T1 ATE49958 T1 AT E49958T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
activities
immunodepressant
aroyl
immuno
Prior art date
Application number
AT85401027T
Other languages
English (en)
Inventor
Pierre Bessin
Jacqueline Bonnet
Original Assignee
Rolland Sa A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rolland Sa A filed Critical Rolland Sa A
Application granted granted Critical
Publication of ATE49958T1 publication Critical patent/ATE49958T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT85401027T 1984-05-25 1985-05-24 Pharmazeutische zusammensetzungen mit immunodepressivwirkung. ATE49958T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8408200A FR2564831B3 (fr) 1984-05-25 1984-05-25 Nouveaux derives des acides aroyl- ou hydroaroyl n-alcoyl pyrrolyl-2 carboxyliques et nouvelles compositions pharmaceutiques a action immuno-suppressive
EP85401027A EP0167426B1 (de) 1984-05-25 1985-05-24 Pharmazeutische Zusammensetzungen mit Immunodepressivwirkung

Publications (1)

Publication Number Publication Date
ATE49958T1 true ATE49958T1 (de) 1990-02-15

Family

ID=9304387

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85401027T ATE49958T1 (de) 1984-05-25 1985-05-24 Pharmazeutische zusammensetzungen mit immunodepressivwirkung.

Country Status (11)

Country Link
US (1) US4617315A (de)
EP (1) EP0167426B1 (de)
JP (1) JPS6110510A (de)
AT (1) ATE49958T1 (de)
AU (1) AU578952B2 (de)
CA (1) CA1251140A (de)
DE (1) DE3575716D1 (de)
DK (1) DK232885A (de)
FR (1) FR2564831B3 (de)
IE (1) IE57994B1 (de)
ZA (1) ZA853886B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223890B1 (de) * 1985-11-29 1990-11-22 Albert ROLLAND S.A. Société dite Arylderivate des Pyrrols, Herstellung und Anwendung als immunologische Heilmittel
FR2641464B1 (fr) * 1989-01-06 1994-06-03 Rolland Sa A Nouvelles compositions pharmaceutiques manifestant des proprietes inhibitrices vis-a-vis de la phospholipase a2
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3752826A (en) * 1970-01-26 1973-08-14 Mcneilab Inc Aroyl substituted pyrroles
GB1592996A (en) * 1977-10-10 1981-07-15 Rolland Sa A Acylated pyrrole carboxylic acids and derivatives thereof
AU4091178A (en) * 1977-10-25 1980-04-24 Merck & Co Inc Substituted mercapto acid amides
JPS54128567A (en) * 1978-03-28 1979-10-05 Teijin Ltd 1-substituted-4-acyl-2-pyrrolecarboxylic acid derivative

Also Published As

Publication number Publication date
FR2564831A1 (fr) 1985-11-29
DE3575716D1 (de) 1990-03-08
IE851229L (en) 1985-11-25
CA1251140A (fr) 1989-03-14
DK232885D0 (da) 1985-05-24
JPH0553772B2 (de) 1993-08-10
FR2564831B3 (fr) 1986-09-05
IE57994B1 (en) 1993-06-02
AU4288285A (en) 1985-11-28
US4617315A (en) 1986-10-14
EP0167426B1 (de) 1990-01-31
DK232885A (da) 1985-11-26
ZA853886B (en) 1986-08-27
JPS6110510A (ja) 1986-01-18
EP0167426A1 (de) 1986-01-08
AU578952B2 (en) 1988-11-10

Similar Documents

Publication Publication Date Title
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
LV10180A (lv) Farmaceitiska kompozicija
LU90192I2 (fr) Desirudine et ses sels et dérivés pharmaceutiquement acceptables (revasc)
ATE71629T1 (de) Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels.
DE59007531D1 (de) Verwendung des Wirkstoffs Azelastin zur Bekämpfung von Psoriasis-Erkrankungen.
NO166939C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater.
DE69327328T2 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
DE69125216D1 (de) Aminoalkanesulfonsäurederivate und pharmazeutische Zusammensetzungen davon zur Prävention oder Behandlung von Herzerkrankungen
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
DE69029693T2 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
ATE49958T1 (de) Pharmazeutische zusammensetzungen mit immunodepressivwirkung.
DE69007065T2 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
ATE110714T1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
NO893256L (no) Fremgangsmaate for fremstilling av furyltiazolderivater.
NO161494C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive benzodiazepiner.
DE3772047D1 (de) Pyrazin zur behandlung von haemodynamischen und metabolischen krankheiten.
DE3887005T2 (de) Mittel zur Behandlung von Nierenbeschwerden.
DE3585070D1 (de) Tetrahydro-1,2,4-oxadiazin-5-thion-derivate.
ATE103491T1 (de) Behandlung von arteriosklerosis durch verabreichung von l-tryptophane oder l-5hydroxytryptophan.
ATE75617T1 (de) Behandlung gewebedegenerativer entzuendungskrankheiten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee